Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution

Z Squared Inc. (NASDAQ: ZSQR) commenced trading on the Nasdaq Global Market on April 27, 2026, following its business combination with Coeptis Therapeutics Holdings, Inc. The company announced a pro rata distribution of Coeptis Holdings, Inc. shares to shareholders of record as of January 2, 2026. Z Squared operates as a vertically integrated computing infrastructure company with facilities across North Carolina, South Carolina, and Iowa, focusing on advanced computing equipment management and power optimization.

04/27/2026, 11:31 AM • Benzinga

Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market

Z Squared, Inc. completed its business combination with Coeptis Therapeutics Holdings, Inc. and will commence trading on the Nasdaq Global Market under ticker symbol 'ZSQR' on Monday, April 27, 2026. The combined company is a vertically integrated computing infrastructure operator with facilities across North Carolina, South Carolina, and Iowa, featuring dynamic power management and hardware lifecycle optimization. Former Z Squared Opco stockholders own approximately 85% of the combined company.

04/24/2026, 4:43 PM • Benzinga

Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing Application

Coeptis Therapeutics announced that Nasdaq has approved the listing application for the post-merger company under the ticker symbol 'ZSQR'. The merger with Z Squared Inc., a digital infrastructure company focused on Dogecoin and Litecoin mining, is expected to close in Q2 2026. Upon closing, Z Squared will become a wholly owned subsidiary and Coeptis will change its name to Z Squared Inc.

04/07/2026, 12:05 PM • Benzinga

Coeptis Receives Shareholder Approval Towards Z Squared Merger

Coeptis Therapeutics Holdings, Inc. announced that its shareholders voted to approve a merger with Z Squared Inc. on January 30, 2026. Upon closing, Z Squared will become a wholly owned subsidiary of Coeptis. Z Squared is a digital infrastructure company focused on cryptocurrency mining operations for Dogecoin and Litecoin networks, planning to deploy 9,800 ASIC miners across facilities in North Carolina, South Carolina, and Iowa.

02/05/2026, 4:00 PM • GlobeNewswire

Coeptis Receives Shareholder Approval Towards Z Squared Merger

Coeptis Therapeutics (NASDAQ: COEP) announced that its shareholders approved the merger with Z Squared Inc. on January 30, 2026. Upon closing, Z Squared will become a wholly owned subsidiary of Coeptis. Z Squared is a digital infrastructure company focused on cryptocurrency mining operations for Dogecoin and Litecoin networks, planning to deploy 9,800 ASIC miners across facilities in North Carolina, South Carolina, and Iowa.

02/05/2026, 4:00 PM • Benzinga

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

Coeptis Therapeutics (NASDAQ: COEP) announced that its S-4 registration statement has been declared effective by the SEC, and proxy materials are being mailed to stockholders for a vote on the merger with Z Squared Inc., scheduled for January 30, 2026. The combined company has applied for Nasdaq listing but approval is not yet assured.

01/06/2026, 8:19 AM • Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies, including Sage Therapeutics, Coeptis Therapeutics, and AvidXchange Holdings.

07/05/2025, 9:51 AM • GlobeNewswire

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT

Law firm Monteverde & Associates is investigating potential merger issues for four companies: Coeptis Therapeutics, Regional Health Properties, Pacific Premier Bancorp, and Southport Acquisition Corporation.

07/03/2025, 5:31 PM • Benzinga

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

Coeptis Therapeutics has filed a registration statement with the SEC regarding a proposed merger with Z Squared Inc., a digital asset compute mining company. The Form S-4 includes a preliminary proxy statement/prospectus about the transaction.

06/26/2025, 8:34 AM • Benzinga